Primary Lung Adenocarcinomas in Children and Adolescents Treated for Pediatric Malignancies

Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer (Impact Factor: 5.28). 11/2010; 5(11):1764-71. DOI: 10.1097/JTO.0b013e3181f69f08
Source: PubMed


Primary lung adenocarcinoma is extremely rare in the pediatric age group. There have been anecdotal reports of lesions that are histologically indistinguishable from adult-type pulmonary adenocarcinoma in young patients after treatment for nonpulmonary cancers. Herein, we present clinical, histopathologic, and molecular data on eight such cases.
Histopathologic evaluation of the tumors was performed according to the World Health Organization classification. Molecular studies for EGFR and KRAS mutations were performed on six patients with sufficient material.
All eight patients were never smokers, four males and four females. Median age at nonpulmonary cancer diagnosis was 14 years (range, 3-23 years). Pulmonary adenocarcinomas were diagnosed at a median age of 15 years (range, 10-24 years); tumors were 0.1 to 2.0 cm in size and in some cases coexisted with metastases from the original cancer. Retrospective review showed that in at least three patients, the nodules were radiographically present before chemotherapy. Of six patients whose tumors were tested for common EGFR and KRAS mutations, two were positive for the former and one for the latter. At a median follow-up of 11 months (range, 2-29 months), six patients remained well without lung nodules and two had additional small, peripheral lung nodules that have not been biopsied.
Pulmonary lesions found in young patients with pediatric cancers can be histologically indistinguishable from lung adenocarcinoma seen in adults, may display typical adenocarcinoma-associated mutations of EGFR and KRAS, and may precede the administration of cytotoxic chemotherapy.

4 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Primary lung adenocarcinoma is a rare entity in the pediatric population, especially in the absence of an underlying congenital pulmonary airway malformation. Primary lung malignancies in pediatric patients are rare and constitute 0.2 % of all childhood malignancies. EGFR mutations and congenital airway malformations have been identified as etiological factors in the development of precancerous lesions that eventually progress to malignancy. The availability of genome sequencing and advanced imaging has made it possible to associate primary lung adenocarcinoma with mutations and structural malformations. Early diagnosis with the help of these techniques may result in surgical resection during early stages of the disease and possibly provide definitive treatment. Development of lung adenocarcinoma in pediatric patients in the absence of the above factors has been recorded anecdotally. It is possible that these patients may harbor a yet unknown set of mutations and recording this cases and preserving their tissues is of vital importance in the detection of these yet unknown etiologies.
    Medical Oncology 03/2012; 29(4):2661-3. DOI:10.1007/s12032-012-0219-7 · 2.63 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Multidetector computed tomography (MDCT) offers an important noninvasive imaging modality for confirmation and further characterization of primary lung and large airway neoplasms encountered in pediatric patients. Children represent a unique challenge in imaging, not only because of unique patient factors (eg, inability to follow instructions, motion, need for sedation) but because of the technical factors that must be optimized to reduce radiation dose. This article reviews an MDCT imaging algorithm, up-to-date imaging techniques, and clinical applications of MDCT for evaluating benign and malignant primary neoplasms of lung and large airway in infants and children.
    Radiologic Clinics of North America 07/2013; 51(4):637-57. DOI:10.1016/j.rcl.2013.04.005 · 1.98 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract The lungs are the most frequent site of metastasis of osteosarcomas; therefore, children with osteosarcoma are submitted to CT scans periodically to detect precocious lung nodules. Although children with osteosarcoma have a higher incidence of a second malignancy than the general population, secondary malignancies in the lungs are rare. The few reported cases show an epithelial origin. Here we report the case of a 13-year-old boy with a primary pulmonary adenocarcinoma diagnosed 3 years after the osteosarcoma diagnosis, and present a review of the literature.
    Pediatric and Developmental Pathology 07/2013; 16(5). DOI:10.2350/13-06-1350-CR.1 · 0.87 Impact Factor
Show more